MEMO1P5

Across TCGA pan-cancer cohorts, MEMO1P5 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated MEMO1P5 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MEMO1P5 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MEMO1P5 expression acts as an unfavorable survival marker, although some lineages such as KIRC and HNSC show a favorable association.

STAD, PAAD, and OV are the cancer types where MEMO1P5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	IV	0.083	0.379	.001	78	view →
PAAD	OS	Tertile	All	0.260	0.622	<.001	72	view →
OV	DFS	Tertile	II,III,IV	0.270	0.390	.010	54	view →
THCA	OS	Tertile	II,III,IV	0.720	0.988	<.001	54	view →
BLCA	DFS	Tertile	All	0.214	0.522	.027	18	view →
SARC	DFS	Tertile	All	0.059	0.613	<.001	18	view →
UCEC	OS	Tertile	III,IV	0.466	0.733	.034	18	view →
LGG	OS	Tertile	All	0.182	0.450	.025	15	view →
KIRC	DFS	Tertile	All	0.903	0.862	.039	12	view →
DLBC	DFS	Tertile	III,IV	0.137	0.761	.014	9	view →
LUAD	DFS	Tertile	III,IV	0.397	0.686	.049	9	view →
HNSC	DFS	Tertile	IV	0.763	0.306	.034	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

MEMO1P5–STAD (DFS)

Open the STAD breakdown →